Company Filing History:
Years Active: 2024
Title: Paul B Harvilla: Innovator in Virology and Therapeutics
Introduction
Paul B Harvilla is a notable inventor based in Nazareth, Pennsylvania. He has made significant contributions to the field of virology, particularly in the development of therapeutic methods for combating viral infections. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Harvilla holds a patent for "Materials and methods for multidirectional biotransportation in virotherapeutics." This patent describes multispecific molecules that include a first binding domain specifically designed to bind to the polymeric immunoglobulin receptor (pIgR) and a second binding domain that targets the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This invention aims to provide effective treatment options for patients infected with SARS-CoV-2.
Career Highlights
Paul B Harvilla is currently associated with Janssen Biotech, Inc., where he continues to work on innovative solutions in the field of biotherapeutics. His expertise and dedication to research have positioned him as a valuable asset in the fight against viral diseases.
Collaborations
Some of his notable coworkers include Rajkumar Ganesan and Adam Zwolak, who collaborate with him on various projects aimed at advancing therapeutic techniques.
Conclusion
Paul B Harvilla's contributions to virology and therapeutics exemplify the impact of innovative thinking in addressing global health issues. His work continues to inspire advancements in the treatment of viral infections.